Publicaciones en colaboración con investigadores/as de University Hospital of Bern (11)

2020

  1. Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trial

    Catheterization and Cardiovascular Interventions, Vol. 96, Núm. 5, pp. E516-E526

2018

  1. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

    The Lancet, Vol. 392, Núm. 10151, pp. 940-949

2017

  1. Arterial Remodeling After Bioresorbable Scaffolds and Metallic Stents

    Journal of the American College of Cardiology, Vol. 70, Núm. 1, pp. 60-74

2016

  1. The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes

    EuroIntervention, Vol. 12, Núm. 1, pp. 79-87

2014

  1. Local and general anaesthesia do not influence outcome of transfemoral aortic valve implantation

    International Journal of Cardiology, Vol. 177, Núm. 2, pp. 448-454

2013

  1. The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: In-hospital results in 4,571 patients

    EuroIntervention, Vol. 8, Núm. 12, pp. 1362-1371

2011

  1. The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: A substudy of the resolute all comers trial

    JACC: Cardiovascular Interventions, Vol. 4, Núm. 4, pp. 432-441

2010

  1. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents

    New England Journal of Medicine, Vol. 363, Núm. 2, pp. 136-146

2002

  1. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: A randomized controlled trial

    Journal of the American Medical Association, Vol. 287, Núm. 24, pp. 3215-3222

1997

  1. Die TREND-Studie (Trial on Reversing ENdothelial Dysfunction): ACE-Hemmung mit Quinapril verbessert die endotheliale vasomotorische Dysfunktion bei Patienten mit koronarer Herzerkrankung

    Munchener Medizinische Wochenschrift, Vol. 139, Núm. 14, pp. 213-221

1996

  1. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: The TREND (Trial on Reversing ENdothelial Dysfunction) study

    Circulation, Vol. 94, Núm. 3, pp. 258-265